Incyte
Price & Volume
Stats
See moreOpen | $98.96 |
Previous Close | $100.09 |
Day Range | $98.85-$101.62 |
52W Range | $53.56-$112.29 |
Market Cap | $19.8B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $5.1B |
Revenue Growth (YoY) | 27.8% |
Gross Profit (12 Mos) | $2.7B |
Diluted EPS | $6.41 |
News
See moreYahoo Finance • 5 hours ago
Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata
Yahoo Finance • 8 days ago
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
Yahoo Finance • 8 days ago
Where is Incyte Corporation (INCY) Headed According to Analysts?
Yahoo Finance • 16 days ago
Pharma companies left out of Trump's drug-pricing deals look for way in
About
CEO | Mr. William J. Meury |
Address | 1801 Augustine Cut-Off, Wilmington, DE, United States, 19803 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,844 |
